Clinical trials
Observational Fibrosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2019 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Arbor Research Collaborative for Health | 1 |
| Daren K. Heyland | 1 |
| Gilead Sciences | 1 |
| Libin Cardiovascular Institute of Alberta | 1 |
| McMaster University | 1 |
| University Health Network, Toronto | 1 |
| University of Arkansas | 1 |
| University of British Columbia | 1 |
| Wako Life Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 11 |
| Fatty Liver | 2 |
| Hepatitis C | 2 |
| Hypersensitivity | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Ascites | 1 |
| Cholestasis | 1 |
| Critical Illness | 1 |
| Death | 1 |
| Edema | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.